|
Treatment of Panic Disorder: Long Term Strategies Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified health advice, travels to or treatment by using a genuine physician. We are not physicians. Always consult your dr. on Treatment of Panic Disorder: Long Term Strategies conditions. Clinical Trials Search.org is a site committed to listing clinical research studies in human subjects. Treatment of Panic Disorder: Long Term Strategies Clinical research trials and Treatment of Panic Disorder: Long Term Strategies health trials occur in hundreds of cities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectivity of new drugs. The propose of the studies / undertakings is to resolve certain human health questions. Clinical trials are a popular means for physicians, government agencies, and private sector companies to locate treatments for all sorts of conditions, including Treatment of Panic Disorder: Long Term Strategies. Treatment of Panic Disorder: Long Term Strategies Clinical Trials and other clinical trials permit volunteers to acquire medical treatment choices before they are available to the masses. Some times the test subjects obtain professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Treatment of Panic Disorder: Long Term Strategies clinical trial. Participants oftentimes recieve the most expert healthcare available for their Treatment of Panic Disorder: Long Term Strategies condition. Hazards are a reality, however, and can include extra or frequent physician visits, health risks (potentially life-endangering), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "T" Clinical Trials Conditions > Treatment of Panic Disorder: Long Term Strategies  Treatment of Panic Disorder: Long Term Strategies
Treatment of Panic Disorder: Long Term Strategies
For Condition: Panic Disorder,Agoraphobia
Status: Recruiting
Sponsor(s): National Institute of Mental Health (NIMH) ,
Synopsis: Cognitive behavior therapy (CBT) with or without medication has been used in the treatment of panic disorder (PD). The purpose of this study is 1) to determine whether nine months of maintenance cognitive-behavior therapy (CBT) significantly improves the likelihood of sustained improvement; and 2) to determine the acute acceptability and efficacy of medication therapy or continued CBT alone among patients who fail to respond sufficiently to an initial course of CBT alone. It has been found that patients with PD respond as well to CBT or medication alone as they do to a combination of the two. Since the combined treatments are expensive and CBT is associated with less risk of medical toxicity compared to medications, CBT alone will be used first. All patients will first receive CBT alone. If the patient responds to this therapy, the patient will be assigned randomly (like tossing a coin) to 1 of 2 groups. One group will continue to receive CBT (maintenance therapy) for 9 months. The other group of responders will not receive any further therapy. If a patient does not respond to CBT alone, he/she will be assigned randomly to 1 of 2 different groups. One group will receive paroxetine; the other will continue to receive CBT for a longer period. The response to treatment will be evaluated to see which regimen works best to treat PD. The study will last approximately 3 years. An individual may be eligible for this study if he/she has panic disorder with no more than mild agoraphobia (fear of being in public places) and is at least 18 years old.
Details: To determine if maintenance CBT produces a more sustained improvement among patients with panic disorder (PD) who respond to an initial course of cognitive behavior therapy (CBT) alone. For those who do not respond sufficiently to CBT alone, to determine if the addition of pharmacotherapy is acceptable and if this improves response among those inadequate responders to CBT alone. This multicenter study builds upon the findings of a prior study comparing imipramine, placebo, CBT, and their combination in the treatment of PD patients with no more than mild agoraphobia. That study found response rates were as high with CBT or imipramine alone as with their combination. Given the added cost of combined treatments, it therefore seems reasonable to begin with monotherapy. Further, following general principles of medical practice, it would be reasonable to initiate treatment with the less invasive cognitive behavioral intervention. It is then important to learn what should be done following initial treatment. All patients initially receive CBT alone. Patients are then randomized into 1 of 2 post-acute studies, depending on response status. Responders are randomized to a maintenance study comparing no maintenance with 9 months of continued CBT. Nonresponders are randomized to a study comparing paroxetine with continued CBT. The following outcomes will be examined: the necessity of maintenance therapy in maintaining response; the ability of adjunct pharmacotherapy to improve the response of patients who did not respond to CBT alone; possible predictors of response and relapse; and possible mediators of response.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: Patients must have: Panic disorder with or without Agoraphobia. All levels of agoraphobia are included.
Total Enrollment: 366
Location and Contact Information:
Overall Study Official:
KatherineShear, Study Chair, University of Pittsburgh
Hillside Hospital Phobia Clinic *Recruiting*
New York City, New York,
United States
Recruiting Jack Gorman
University of Pittsburgh, Department of Psychiatry, Panic, Anxiety and Traumatic Grief Program *No longer recruiting*
Pittsburgh, Pennsylvania, 15213
United States
No longer recruiting
Yale University, Department of Psychiatry, Anxiety Disorders Research Clinic *Recruiting*
New Haven, Connecticut,
United States
Recruiting Scott Woods
Boston University, Department of Psychology, Center for Anxiety and Related Disorders *Recruiting*
Boston, Massachusetts,
United States
Recruiting David Barlow
Additional Information:
Study ID Numbers: MH045964-11; MH45965 -11,MH045966-10,MH045963-10
Study Start Date: February 1999
Record last reviewed: July 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000368
Other Panic Disorder Studies:
1. Vestibular Dysfunction In Adult Patients With Panic Disorder With or Without Agoraphobia
2. Pilot Study of Vestibular Rehabilitation Training for Panic Disorder With Vestibular Dysfunction
3. Panic Disorder Study
4. Treatment of Panic Disorder: Long Term Strategies
5. Therapy for Depression with Co-occurring Panic or Anxiety Symptoms
Related Studies:
Other Panic Disorder Clinical Trials
Other Pennsylvania Clinical Trials
Other Pittsburgh Clinical Trials
Treatment of Panic Disorder: Long Term Strategies
|
|
|
|
|
|
|
|
